Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt small index

Pediatric Brain Tumor: early-phase trial registry

7 of 10 indexed Pediatric Brain Tumor trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 7 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Pediatric Brain Tumor: 10 US clinical trials tracked, 7 recruiting.

Pediatric Brain Tumor is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Cellectar Biosciences, running 1 of these trials.

Enrollment posture brief

Registry condition pediatric-brain-tumor

OPEN 7 | RECR 70% | LATE 0 | EARLY 4 | RANK #1724 | SPON 1

Nearest open-share peer: Advanced Solid Tumor (70% recruiting · 190 trials)

Acute Leukemia of Ambiguous 80%Pediatric Brain Tumor (this)70%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Pediatric Brain Tumor

Pediatric Brain Tumor lists 7 open slots (70% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pediatric Brain Tumor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pediatric Brain Tumor is recruiting above its size-band peers.

    7 of 10 indexed trials (70%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Pediatric Brain Tumor trials is spread across many organizations.

    Cellectar Biosciences accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Most Pediatric Brain Tumor trials plan to enrol fewer than 100 people.

    Median target enrolment is 42 among the 10 trials that report a genuine target (sentinel values excluded). 10 of those (100%) plan for fewer than 100 participants.

  4. Pediatric Brain Tumor research is mostly interventional.

    8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 14

Open and recent trials

10 total, page 1 of 1

RECRUITING 75 participants

Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)

University of Wisconsin, Madison

NCT06981156

RECRUITING NA 72 participants

Survivors Journey+

Children's Hospital Medical Center, Cincinnati

NCT07321353

RECRUITING NA 50 participants

Feasibility/Acceptability of Attentional-Control Training in Survivors

Children's National Research Institute

NCT05528939

RECRUITING NA 30 participants

High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study

Dana-Farber Cancer Institute

NCT05740839

RECRUITING Phase 1 24 participants

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Sabine Mueller, MD, PhD

NCT05887882

RECRUITING Phase 1 20 participants

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Washington University School of Medicine

NCT05521984

RECRUITING Phase 1 18 participants

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Stanford University

NCT07087002

ACTIVE NOT RECRUITING NA 44 participants

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

University of California, San Francisco

NCT03739372

ACTIVE NOT RECRUITING 42 participants

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Memorial Sloan Kettering Cancer Center

NCT03208387

ACTIVE NOT RECRUITING Phase 1 30 participants

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Cellectar Biosciences

NCT03478462

Phase Distribution

PhaseTrial count
Phase 1 4

Named interventions

Most-linked intervention names on Pediatric Brain Tumor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cyclophosphamide Drug
2 trials
Beery Test of Visual Motor Integration 6th edition Behavioral
1 trials
California Verbal Learning Test (CVLT-C) Behavioral
1 trials
Wechsler Intelligence Scale for Children - 5th edition (WISC-V) Behavioral
1 trials
Resting state functional connectivity MRI (rs-fcMRI) Diagnostic test
1 trials
Diffusion tensor imaging (DTI) Diagnostic test
1 trials
Specialized tumor board recommendation Other
1 trials
CLR 131 Drug
1 trials

US sites by state

Facility locations filed on Pediatric Brain Tumor trials. A trial with sites in several states counts in each.

Ohio 4 trials
California 4 trials
Washington 3 trials
Missouri 3 trials
Wisconsin 2 trials
Texas 2 trials
New York 2 trials
Maryland 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pediatric Brain Tumor page

10 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pediatric Brain Tumor condition card totals 10 registered trials; most-linked intervention Cyclophosphamide; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.